Business
Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications
NASHVILLE, Tenn.--(BUSINESS WIRE)-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that Mike Biega has
About this update from Harrow, Inc.
[{"type":"text","content":" NASHVILLE, Tenn.--(BUSINESS WIRE)--\nHarrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that Mike Biega has joined Harrow as Vice President of Investor Relations and Communications, succeeding Jamie Webb, Director of Communications and Investor Relations, who recently announced her retirement. Jamie will remain in her role into August to support a smooth and effective transition.\n\n\n“We are excited to welcome Mike to the Harrow Family. His wealth of experience in investor relations and strategic communications will be a tremendous asset as we pursue our objective of becoming the leading U.S. ophthalmic pharmaceutical company,” said Mark L. Baum, Chief Executive Officer of Harrow. “I am looking forward to seeing Mike strengthen our engagement with the investment community, communicating our vision, performance, and history of long-term value creation for all Harrow stakeholders.”\n\n\nBaum continued, “On behalf of the entire Harrow Family, I want to sincerely thank Jamie for her support, leadership, professionalism, and unwavering commitment over the years. She has been a trusted partner to our leadership team and a valued voice in our communications strategy. We are thankful for her continued support during this transition and wish her all the best in her well-earned retirement.”\n\n\nMike joins Harrow with over a decade of experience in biotech investor relations and communications. Most recently, he served as Sr. Director, Head of Investor Relations at Sensei Biotherapeutics, where he led the investor relations and communications function. Prior to joining Sensei, Mike was a Managing Director and a member of the leadership team at Solebury Trout, a leading biotech investor relations and strategic advisory firm. During his time there, he led the investor relations strategy and execution for several public and private biotech companies. Mike started his career on the equity sales desk at Summer Street Research Partners, an institutional equity research and trading firm focused exclusively on the healthcare sector.\n\n\n“I’m thrilled to join Harrow at such an exciting time in its evolution,” said Mike Biega. “Harrow’s commitment to delivering accessible, affordable, and differentiated ophthalmic solutions resonates deeply, and I look forward to working closely with the leadership te...